Drug Search Results
More Filters [+]

Tedisamil

Alternative Names: tedisamil
Latest Update: 2023-07-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Voltage-Gated Potassium Channel Blocker

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Sweden

Approved Indications: None

Known Adverse Events: None

Company: Solvay Pharm
Company Location: 1120 BRUSSELS C9 00000
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Tedisamil

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Atrial Fibrillation|Atrial Flutter

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

S219.3.118

P3

Completed

Atrial Flutter|Atrial Fibrillation

2006-03-01

S219.3.116

P3

Completed

Atrial Flutter|Atrial Fibrillation

2006-03-01

S219.3.117

P3

Completed

Atrial Flutter|Atrial Fibrillation

2006-01-01

2004-000346-21

P3

Active, not recruiting

Atrial Fibrillation|Atrial Flutter

2005-03-06

Recent News Events